Episode Details
Back to EpisodesSemaglutide vs. Tirzepatide: Are We Closing the Gap?
Episode 125
Published 5 months, 2 weeks ago
Description
How the STEP-UP trial came to life, and what made the 7.2mg dose possible
What the data actually says about weight loss and side effects at higher doses
Why trial design, pharmacokinetics, and estimands matter more than you think
What’s coming next in obesity meds: duals, triples, and even antagonists
The real talk on intermittent fasting, access issues, and preaching vs. science
Sign up for Dr. Spencer''s Clinic
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.